Jardiance is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Jardiance is considered an adjunct treatment to diet and exercise. Jardiance is also referred to by its drug name, Empagliflozin.
Jardiance is a sodium-glucose transporter 2 (SGLT2). Jardiance is believed to work by causing excess glucose to be eliminated in the urine.
How do I take it?
Prescribing information states that Jardiance is generally taken once daily in the morning, with or without food.
Jardiance comes in tablet form.
The FDA-approved label for Jardiance lists common side effects including urinary tract infections and yeast infections of the vagina or the skin around the penis.
Rare but serious side effects listed for Jardiance include changes in urination, dehydration, and increased cholesterol levels.